Evidence map›Paper›PMID 26953160›Full record

ArticleDiabetes2016

Proinsulin Expression Shapes the TCR Repertoire but Fails to Control the Development of Low-Avidity Insulin-Reactive CD8+ T Cells.

James A Pearson, Terri C Thayer, James E McLaren, Kristin Ladell, Evy De Leenheer, Amy Phillips, Joanne Davies, Dimitri Kakabadse, Kelly Miners, Peter Morgan and 3 more

Open access · bronzeAbstract read
In one paragraph

Article in Diabetes, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
2.1field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

James A PearsonDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Terri C ThayerDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
James E McLarenCellular Immunology Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Kristin LadellCellular Immunology Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Evy De LeenheerDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Amy PhillipsDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Joanne DaviesDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Dimitri KakabadseDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Kelly MinersCellular Immunology Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
Peter MorganCardiff Business School, Cardiff University, Wales, U.K.
Li WenSection of Endocrinology, School of Medicine, Yale University, New Haven, CT.
David A PriceCellular Immunology Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K.
F Susan WongDiabetes Research Group, Division of Infection and Immunity, School of Medicine, Cardiff University, Wales, U.K. wongfs@cardiff.ac.uk.
Yale University · US

Funding

Yale Diabetes Research CenterP30DK045735 · NIDDK · YALE UNIVERSITY · PI Kevan C Herold, GERALD I SHULMAN · 1993 to 2026
$44.0M
Dendritic cells in immuno-metabolic disorder in mouse and manR01DK100500 · NIDDK · YALE UNIVERSITY · PI WEN, LI · 2014 to 2017
$1.4M
Diabetes UK 08/3767Medical Research Council G0901155Wellcome TrustWellcome Trust 100326Z/12/Z
6 · The paper itself

Abstract

NOD mice, a model strain for human type 1 diabetes, express proinsulin (PI) in the thymus. However, insulin-reactive T cells escape negative selection, and subsequent activation of the CD8(+) T-cell clonotype G9C8, which recognizes insulin B15-23 via an αβ T-cell receptor (TCR) incorporating TRAV8-1/TRAJ9 and TRBV19/TRBJ2-3 gene rearrangements, contributes to the development of diabetes. In this study, we used fixed TRAV8-1/TRAJ9 TCRα-chain transgenic mice to assess the impact of PI isoform expression on the insulin-reactive CD8(+) T-cell repertoire. The key findings were: 1) PI2 deficiency increases the frequency of insulin B15-23-reactive TRBV19(+)CD8(+) T cells and causes diabetes; 2) insulin B15-23-reactive TRBV19(+)CD8(+) T cells are more abundant in the pancreatic lymph nodes of mice lacking PI1 and/or PI2; 3) overexpression of PI2 decreases TRBV19 usage in the global CD8(+) T-cell compartment; 4) a biased repertoire of insulin-reactive CD8(+) T cells emerges in the periphery regardless of antigen exposure; and 5) low-avidity insulin-reactive CD8(+) T cells are less affected by antigen exposure in the thymus than in the periphery. These findings inform our understanding of the diabetogenic process and reveal new avenues for therapeutic exploitation in type 1 diabetes.

Indexed as

Antibody AffinityAnimalsCD4-Positive T-LymphocytesCD8-Positive T-LymphocytesDiabetes Mellitus, Type 1InsulinMiceMice, Inbred NODMice, TransgenicProinsulinReceptors, Antigen, T-Cell, alpha-betaInsulinProinsulinReceptors, Antigen, T-Cell, alpha-beta

Identifiers

PMID26953160
PMCPMC5310213
OpenAlexW2297529967

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.